跳至主要内容
临床试验/NL-OMON44553
NL-OMON44553撤回不适用

Prospective Observational Multicenter Evaluation of the Use of the G7 BiSpherical Shell - G7 PMCS study

Zimmer GmbH0 个研究点目标入组 35 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
Zimmer GmbH
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Patient capable of understanding the surgeon*s explanations and following his
  • instructions, able and willing to participate in the follow-up program and who gave
  • consent to take part in the study.
  • - Patients aged of 18 years or more whose skeleton reached bone maturity.
  • - Noninflammatory degenerative joint disease, including osteoarthritis and avascular
  • - Rheumatoid arthritis.
  • - Correction of functional deformity.
  • - Treatment of non-union, femoral neck fracture, and trochanteric fractures of the
  • proximal femur with head involvement, unmanageable by other techniques.
  • - Revision procedures where other treatment or devices have failed.;Inclusion criteria specific for patients receiving the G7 BiSpherical Shell with the Freedom
  • Constrained Liner:
  • - The Biomet G7 Freedom Constrained Liner is indicated for use as a component of
  • a total hip prosthesis in primary and revision patients at high risk of dislocation due
  • to a history of prior dislocation, bone loss, joint or soft tissue laxity, neuromuscular
  • disease, or intraoperative instability, and for whom all other options to constrained
  • acetabular components have been considered.

排除标准

  • Absolute exclusion criteria are:
  • - Infection, sepsis, osteomyelitis.;Relative exclusion criteria include:
  • - Uncooperative patient or patient with neurologic disorders who is incapable of
  • following directions.
  • - Osteoporosis.
  • - Metabolic disorders which may impair bone formation.
  • - Osteomalacia.
  • - Distant foci of infections which may spread to the implant site.
  • - Rapid joint destruction, marked bone loss or bone resorption apparent on
  • roentgenogram.
  • - Vascular insufficiency, muscular atrophy, neuromuscular disease.
  • - Patient unwilling or unable to give consent, or to comply with the follow-up program
  • - Patient known to be pregnant or breastfeeding.
  • - Patient presenting any condition that would, in the judgment of the Investigator,
  • place the patient at undue risk or interfere with the study.
  • - Patient institutionalized or known drug abuser or alcoholic or anyone who cannot
  • understand what is required of them.
  • - Patient belonging to a vulnerable population.;Exclusion criteria specific for patients receiving the G7 BiSpherical Shell with the G7
  • Freedom Constrained Liner:
  • - Bone or musculature compromised by disease, infection, or prior implantation that
  • cannot provide adequate support or fixation for the prosthesis.

研究者

发起方
Zimmer GmbH

相似试验